Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Exact Sciences Corp Revenue & Financial Statements
Exact Sciences Corp reported revenue of $2.8B for the fiscal year ended December 31, 2024, up 10.4% year over year, with net income of $(1.0B) and diluted EPS of $-5.59.
- Company
- Exact Sciences Corp EXAS · NASDAQ
- Latest fiscal year
- FY ended Dec 31, 2024
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.8B | 2.1B | 2.5B | 2.8B |
| Cost of revenue | 354.3M | 458.8M | 574.4M | 654.2M | 840.1M |
| Gross profit | 346.0M | 333.5M | 1.5B | 1.8B | 1.9B |
| Operating income | (768.0M) | (855.7M) | (593.5M) | (215.0M) | (1.0B) |
| Pretax income | (406.0M) | (41.0M) | (15.3M) | 2.4M | 145K |
| Net income | (847.9M) | (597.6M) | (627.3M) | (197.5M) | (1.0B) |
| Diluted EPS | -2.79 | -3.48 | -3.54 | -1.13 | -5.59 |
| EBITDA | (698.6M) | (770.4M) | (493.4M) | — | (929.0M) |
Quarterly
| USD | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | (7.9M) | (7.9M) | 111K | (9.6M) | 713.4M | 706.8M | 811.1M | 850.7M |
| Cost of revenue | 168.5M | 170.1M | 189.8M | 196.1M | 284.1M | 206.2M | 248.6M | 266.8M |
| Gross profit | (176.4M) | (178.0M) | (189.7M) | (205.7M) | 429.3M | 500.5M | 562.5M | 583.9M |
| Operating income | 6.8M | (106.7M) | (26.3M) | (39.4M) | (876.4M) | (96.0M) | (2.1M) | (25.5M) |
| Pretax income | 1.0M | (108.4M) | (14.3M) | (37.4M) | (876.0M) | (101.0M) | (57K) | (17.8M) |
| Net income | 794K | (110.2M) | (15.8M) | (38.2M) | (864.6M) | (99.3M) | 888K | (19.4M) |
| Diluted EPS | 0.00 | — | -0.09 | -0.21 | -4.70 | -0.54 | -0.01 | -0.10 |
| EBITDA | 36.1M | (76.1M) | 3.4M | (9.1M) | (847.3M) | (66.0M) | 29.0M | 6.2M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Total assets | 4.9B | 6.7B | 6.2B | 6.5B | 5.9B |
| Current assets | 2.2B | 1.4B | 982.3M | 1.2B | 1.6B |
| Cash & equivalents | 1.5B | 315.5M | 242.5M | 605.4M | 600.9M |
| Total liabilities | 2.1B | 3.3B | 3.2B | 3.3B | 3.5B |
| Current liabilities | 575.8M | 517.1M | 412.7M | 514.7M | 732.2M |
| Long-term debt | — | — | — | — | — |
| Total debt | — | — | — | — | — |
| Stockholders’ equity | 2.8B | 3.4B | 3.0B | 3.1B | 2.4B |
| Net debt | — | — | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Operating cash flow | 136.5M | (102.2M) | (223.6M) | 156.1M | 210.5M |
| Investing cash flow | (702.0M) | (1.1B) | 74.1M | 49.7M | (442.2M) |
| Financing cash flow | 1.9B | 8.5M | 76.5M | 159.8M | 231.9M |
| Capital expenditure | 64.4M | 135.8M | 214.5M | 124.2M | 136.0M |
| Free cash flow | 72.1M | (238.0M) | (438.0M) | 31.9M | 74.5M |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 152.9M | 253.1M | 206.8M | 231.3M | 214.9M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every EXAS filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.